Filing Details
- Accession Number:
- 0001209191-18-053847
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-10-03 16:42:02
- Reporting Period:
- 2018-08-21
- Accepted Time:
- 2018-10-03 16:42:02
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1411690 | Bionano Genomics Inc | BNGO | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1189124 | L David Barker | C/O Bionano Genomics, Inc. 9640 Towne Centre Drive, Suite 100 San Diego CA 92121 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-08-21 | 3,894 | $6.47 | 3,894 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Common Stock Warrants (right to buy) | Acquisiton | 2018-08-21 | 3,894 | $6.47 | 3,894 | $6.47 |
Common Stock | Stock Option (Right to Buy) | Acquisiton | 2018-10-01 | 10,516 | $0.00 | 10,516 | $7.77 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
3,894 | 2023-08-21 | No | 4 | P | Direct | |
10,516 | 2028-09-30 | No | 4 | A | Direct |
Footnotes
- The price reported in column 4 is a weighted average price. These units, with each unit consisting of one share of common stock and a warrant to purchase one share of common stock, were purchased in multiple transactions at prices ranging from $6.37 to $6.4971, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of units purchased at each separate price within the ranges set forth herein.Units purchased at a price of $6.47 per unit, .
- September 21, 2018 or such earlier date as Roth Capital Partners LLC, as representative of the underwriters in the Company's Initial Public Offering, shall determine.
- The shares subject to the option shall vest monthly over 36 months beginning on the one-month anniversary of October 1, 2018 (the "Vesting Commencement Date") such that the option shall be fully vested and exercisable on the three year anniversary of the Vesting Commencement Date.